Evermay Wealth Management LLC Pfizer Inc Transaction History

Evermay Wealth Management LLC

$806 Million
Q2 2025

A detailed history of Evermay Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Evermay Wealth Management LLC holds 12,211 shares of PFE stock, worth $334,215. This represents 0.04% of its overall portfolio holdings.

Number of Shares

12,211

Previous 14,095 13.37%

Holding current value

$334,215

Previous $357,000 17.37%

% of portfolio

0.04%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$21.59 - $24.84 $40,675 - $46,798	-1,884 Reduced 13.37%	12,211 $295,000
Q1 2025 May 07, 2025	BUY	$25.01 - $27.13 $15,906 - $17,254	636 Added 4.73%	14,095 $357,000
Q4 2024 Jan 23, 2025	SELL	$24.8 - $30.19 $135,358 - $164,777	-5,458 Reduced 28.85%	13,459 $357,000
Q3 2024 Oct 25, 2024	SELL	$27.7 - $31.39 $46,397 - $52,578	-1,675 Reduced 8.13%	18,917 $547,000
Q2 2024 Aug 01, 2024	BUY	$25.26 - $29.6 $142,365 - $166,825	5,636 Added 37.68%	20,592 $576,000
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $53,385 - $61,303	-2,062 Reduced 12.12%	14,956 $415,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $31,199 - $40,524	-1,194 Reduced 6.56%	17,018 $489,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $61,223 - $70,834	-1,695 Reduced 8.51%	18,212 $668,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $328,039 - $427,059	-8,328 Reduced 29.5%	19,907 $812,000
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $69,722 - $91,015	-1,670 Reduced 5.58%	28,235 $0
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $18,247 - $22,276	417 Added 1.41%	29,905 $1.31 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $930 - $1,103	-20 Reduced 0.07%	29,488 $1.55 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $539,163 - $668,091	-11,785 Reduced 28.54%	29,508 $1.53 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $78,466 - $116,313	1,899 Added 4.82%	41,293 $2.44 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $657,123 - $844,131	-16,742 Reduced 29.82%	39,394 $1.69 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $36,484 - $41,330	-1,016 Reduced 1.78%	56,136 $2.2 Million
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $69,692 - $78,599	-2,081 Reduced 3.51%	57,152 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $23,964 - $30,472	716 Added 1.22%	59,233 $2.18 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $49,752 - $58,370	1,567 Added 2.75%	58,517 $2.15 Million
Q2 2020 Jul 20, 2020	BUY	$30.12 - $36.54 $55,722 - $67,599	1,850 Added 3.36%	56,950 $1.86 Million
Q1 2020 Apr 24, 2020	SELL	$27.03 - $38.62 $28,922 - $41,323	-1,070 Reduced 1.9%	55,100 $1.8 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $177,372 - $201,295	-5,388 Reduced 8.75%	56,170 $2.2 Million
Q3 2019 Oct 29, 2019	BUY	$32.49 - $42.13 $16,829 - $21,823	518 Added 0.85%	61,558 $2.21 Million
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $113,713 - $127,674	-3,075 Reduced 4.8%	61,040 $2.64 Million
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $4,500 - $4,944	120 Added 0.19%	64,115 $2.72 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $17,503 - $19,956	-455 Reduced 0.71%	63,995 $2.79 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $50,326 - $61,042	-1,460 Reduced 2.22%	64,450 $2.84 Million
Q2 2018 Aug 06, 2018	BUY	$32.98 - $35.16 $12,037 - $12,833	365 Added 0.56%	65,910 $2.39 Million
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $3,350 - $3,887	105 Added 0.16%	65,545 $2.33 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $561,994 - $596,295	16,897 Added 34.81%	65,440 $2.37 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $1.5 Million - $1.66 Million	48,543	48,543 $1.73 Million

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermay Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermay Wealth Management LLC with notifications on news.

Account

Evermay Wealth Management LLC Pfizer Inc Transaction History